Originally written on NESN.com  |  Last updated 11/18/14
NEW YORK — San Diego Padres catcher Yasmani Grandal has been suspended 50 games because of a positive test for testosterone. The commissioner’s office announced the drug penalty on Wednesday. The ban will take effect at the start of next season. Grandal made his big league debut this year. He hit .297 with eight home runs and 36 RBIs in 60 games. He turns 24 on Thursday. “I apologize to the fans, my teammates and to the San Diego Padres,” he said in a statement. “I was disappointed to learn of my positive test and under the joint drug program. I am responsible for what I put into my body. I must accept responsibility for my actions and serve my suspension.” Grandal was acquired by the Padres from Cincinnati last December. The Cuban native was traded by the Reds with pitcher Edinson Volquez in a package for pitcher Mat Latos. There have been seven suspensions this year under the major league program. Six of them were for peformance-enhancing drugs — including Melky Cabrera and Bartolo Colon for positive testosterone tests — and one for a stimulant. The seven suspensions are the most in a year under the big league drug program since there were eight in 2007. There have been 101 suspensions this year under the minor league drug problem.
GET THE YARDBARKER APP:
Ios_download En_app_rgb_wo_45
MORE FROM YARDBARKER

Jim Kelly: There is no doubt Tom Brady cheated

Warriors hang on, edge Rockets in Game 2 thriller

Farrell 'not ruling anything out' as Red Sox's struggles persist

Gretzky: Connor McDavid could be the next Gretzky

Bucs' Clint McDonald: Jameis Winston already leading team

LIKE WHAT YOU SEE?
GET THE DAILY NEWSLETTER:

Dana White: Rousey vs. Cyborg would break UFC PPV record

Report: Smith child abuse investigation 'sexual in nature'

DeGale: ‘At the end of the day I’m better’ than Dirrell

Belichick suspected Tom Brady wasn't being honest with him

Johnny Manziel to be a full participant in OTAs

Ex-players sue NFL for conspiring to push painkillers

Ranking the NBA Playoffs' most significant injuries

WATCH: Will Smith ejected for foreign substance on arm

Guy behind NFL's social media trolling of Pats is a Jets fan?

In defense of 76ers general manager Sam Hinkie

Madison Bumgarner homered off of Clayton Kershaw

Would both Towns, Okafor prefer not being the No. 1 pick?

Spoiler Alert Central: Pitfalls in online viewing of live sports

NYPD officer takes photo with 'Eli's brother' at Letterman

Post-combine NBA Draft big board: Top 30

NFL suspends Bills Marcell Dareus for violating substance abuse policy

Astros surprising, but can get better with prospects like Correa

JR Smith prefers taking contested shots to open shots

MLB News
Delivered to your inbox
You'll also receive Yardbarker's daily Top 10, featuring the best sports stories from around the web. Customize your newsletter to get articles on your favorite sports and teams. And the best part? It's free!

By clicking "Sign Me Up", you have read and agreed to the Fox Sports Digital Privacy Policy and Terms of Use. You can opt out at any time. For more information, please see our Privacy Policy.
the YARDBARKER app
Get it now!
Ios_download En_app_rgb_wo_45

Jim Kelly: No doubt Tom Brady cheated

Post-combine NBA Draft big board: Top 30

Ex-players sue NFL for conspiring to push painkillers

Astros surprising, but can get better with Correa

Here come the Giants

Aaron Hernandez got new tattoo in prison

TUF weekly recap by NOS® Energy Drink

Ten players who could benefit due to PAT rule change

Five QBs set for breakout campaigns

Report: Lakers will pursue Thibodeau

MLS leaders struggling with attendance

LBS: I was a contestant on Sports Jeopardy!

Today's Best Stuff
For Bloggers

Join the Yardbarker Network for more promotion, traffic, and money.

Company Info
Help
What is Yardbarker?

Yardbarker is the largest network of sports blogs and pro athlete blogs on the web. This site is the hub of the Yardbarker Network, where our editors and algorithms curate the best sports content from our network and beyond.